CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

Lisata deal propels Marea’s drug pipeline to Wall Street

Positive
AI Analysis

Summary

Lisata acquires Marea in a deal coupled with a $225 million financing round to support development of two mid-stage drugs for cardiovascular and endocrine conditions.

Importance:7/10
Sentiment:
0.60
M&Afinancingpipeline expansioncardiovascularendocrinePhase 2

Read the original article

Published by BioPharma Dive on September 17, 2026 9:39 PM

Read Original